O

Open Orphan PLC
LSE:ORPH

Watchlist Manager
Open Orphan PLC
LSE:ORPH
Watchlist
Price: 10 GBX 5.26% Market Closed
Market Cap: 67.1m GBX

Wall Street
Price Targets

ORPH Price Targets Summary
Open Orphan PLC

There are no price targets for ORPH.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Open Orphan PLC Competitors:
Price Targets
LAB
Standard BioTools Inc
61% Upside
BANB
Bachem Holding AG
14% Upside
BIOT
Biotage AB
3% Upside
SHC
Sotera Health Co
3% Downside
INNOVACAP
Innova Captab Ltd
23% Upside
ONESOURCE
Onesource Specialty Pharma Ltd
24% Upside
EVT
Evotec SE
49% Upside
300759
Pharmaron Beijing Co Ltd
7% Upside

Revenue
Forecast

Revenue Estimate
Open Orphan PLC

For the last 1 year the compound annual growth rate for Open Orphan PLC's revenue is 32%. The projected CAGR for the next 1 year is 43%.

32%
Past Growth
43%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Open Orphan PLC

Operating Income forecast
is not available for
Open Orphan PLC

Net Income
Forecast

Net Income Estimate
Open Orphan PLC

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ORPH's stock price target?
Not Available

ORPH doesn't have any price targets made by Wall Street professionals.

What is Open Orphan PLC's Revenue forecast?
Projected CAGR
43%

For the last 1 year the compound annual growth rate for Open Orphan PLC's revenue is 32%. The projected CAGR for the next 1 year is 43%.

Back to Top